Banyan Capital Management Inc. lessened its position in shares of Markel Group Inc. (NYSE:MKL – Free Report) by 0.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,788 shares of the insurance provider’s stock after selling 93 shares during the period. Markel Group comprises 10.3% of Banyan Capital Management Inc.’s holdings, making the stock its 3rd largest position. Banyan Capital Management Inc. owned approximately 0.08% of Markel Group worth $16,998,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of MKL. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Markel Group in the second quarter worth $55,000. Ables Iannone Moore & Associates Inc. bought a new stake in Markel Group during the 4th quarter worth about $57,000. GAMMA Investing LLC boosted its stake in shares of Markel Group by 90.0% during the 1st quarter. GAMMA Investing LLC now owns 38 shares of the insurance provider’s stock worth $58,000 after buying an additional 18 shares during the last quarter. Evermay Wealth Management LLC acquired a new position in shares of Markel Group during the 1st quarter worth about $75,000. Finally, Crewe Advisors LLC bought a new position in shares of Markel Group in the 1st quarter valued at about $81,000. Institutional investors and hedge funds own 77.12% of the company’s stock.
Markel Group Price Performance
Shares of NYSE MKL opened at $1,584.66 on Friday. Markel Group Inc. has a twelve month low of $1,295.65 and a twelve month high of $1,670.24. The company has a market cap of $20.61 billion, a PE ratio of 8.56 and a beta of 0.73. The business’s 50 day moving average price is $1,566.36 and its two-hundred day moving average price is $1,552.16. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.29.
Wall Street Analysts Forecast Growth
MKL has been the topic of several analyst reports. Citigroup upped their target price on Markel Group from $1,435.00 to $1,450.00 and gave the stock a “sell” rating in a report on Tuesday, July 23rd. TD Cowen assumed coverage on Markel Group in a report on Tuesday, July 9th. They issued a “buy” rating and a $1,986.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $1,626.83.
Check Out Our Latest Stock Report on Markel Group
Insider Activity
In related news, Director Lawrence A. Cunningham purchased 20 shares of the stock in a transaction on Monday, August 5th. The shares were purchased at an average cost of $1,512.50 per share, with a total value of $30,250.00. Following the acquisition, the director now directly owns 743 shares in the company, valued at $1,123,787.50. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 1.71% of the company’s stock.
About Markel Group
Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.
Featured Stories
- Five stocks we like better than Markel Group
- What is the Euro STOXX 50 Index?
- Roku Stock Gains New Buy Rating: Here’s Why Analysts Are Bullish
- Insider Trading – What You Need to Know
- Prepare for a Silver Surge: Best Mining Stocks to Watch Now
- Options Trading – Understanding Strike Price
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.